Mosunetuzumab Monotherapy is an effective and well-tolerated Treatment Option in Patients with relapsed/refractory follicular Lymphoma who have previously received plus or minus 2 Lines of Therapy: Key Results from a Phase I/II Study

G. Hess,L. E. Budde,L. H. Sehn,M. Matasar,S. J. Schuster,S. Assouline,P. Giri,J. Kuruvilla,M. Canales,S. Dietrich,K. Fay,M. Ku,L. Nastoupil,M. C. Wei,S. Yin,M. Y. Doral,C. -C. Li,H. Huang,R. Negricea,E. Penuel,C. O'Hear,N. L. Bartlett

ONCOLOGY RESEARCH AND TREATMENT（2022）

引用 0|浏览21
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要